Our magazine is free!

for living with diabetes

Articles related to "All Wales Medicines Strategy Group" »

Novo Nordisk UK launches new type 2 diabetes treatment

Friday, April 5th, 2019 | 0 Comments
Novo Nordisk UK has announced that Ozempic (semaglutide), a new once-weekly GLP-1 analogue injection for the treatment of Type 2 diabetes is now available in the UK. Ozempic works by mimicking the function of the GLP-1 (human glucagon-like peptide-1) hormone produced in the read more »
""